Alteration of Bone Density, Microarchitecture, and Strength in Patients with Camurati–Engelmann Disease: Assessed by HR‐pQCT-Reference-Cited by-同舟云学术

Alteration of Bone Density, Microarchitecture, and Strength in Patients with Camurati–Engelmann Disease: Assessed by HR‐pQCT

Published:2021-09-28 Issue:1 Volume:37 Page:78-86
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J of Bone & Mineral Res

Author:

Li Qian¹,Zhao Zhen¹,Wu Bo¹,Pang Qianqian¹,Cui Lijia¹,Zhang Li¹,Jiang Yan¹^ORCID,Wang Ou¹,Li Mei¹^ORCID,Xing Xiaoping¹^ORCID,Hu Yingying¹,Yu Wei²,Meng Xunwu¹,Jiajue Ruizhi¹,Xia Weibo¹^ORCID

Affiliation:

1. Department of Endocrinology, Key Laboratory of Endocrinology, NHC, State Key Laboratory of Complex Severe and Rare Diseases Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing China

2. Department of Radiology Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing China

Funder

Foundation for Innovative Research Groups of the National Natural Science Fund of China

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.4436

Reference34 articles.

1. Mutations in the gene encoding the latency-associated peptide of TGF-β1 cause Camurati-Engelmann disease

2. Progressive diaphyseal dysplasia (Camurati-Engelmann): radiographic follow-up and CT findings.